CETA EU–Canada – Origin Cumulation Pharmaceutical Products

Quelle: https://ec.europa.eu/trade/policy/countries-and-regions/countries/canada/

Under CETA, origin cumulation allows for the consideration of the actual origins of inputs from the EU and Canada in the determination of the origin of pharmaceutical products, thus facilitating trade between these regions.

Related Terms

You might also be interested in these terms

CETA EU-Canada

CETA (Comprehensive Economic and Trade Agreement) is a free trade agreement between the European Union and Canada that reduces trade barriers and prom...

Learn more

EFTA-Canada FTA – Origin Cumulation Pharmaceutical Products

Origin cumulation refers to the practice wherein the origin of goods in a trade agreement is determined such that products from the EFTA region and Ca...

Learn more

CETA EU–Canada – Origin Cumulation Shoes

Origin cumulation under the CETA agreement between the EU and Canada allows materials produced in either of the two regions to be used in fulfilling t...

Learn more

CAFTA-DR – Origin Cumulation Pharmaceutical Products

CAFTA-DR – Origin cumulation refers to the mechanism under the Central America Free Trade Agreement – Dominican Republic that allows countries to appl...

Learn more

CETA EU-Canada - Origin Cumulation Ceramics

The origin cumulation under the CETA agreement allows ceramic products manufactured in Canada from materials of European origin to be considered as or...

Learn more

CPTPP – Origin Accumulation Pharmaceutical Products

The CPTPP origin accumulation refers to a regulation under the Comprehensive and Progressive Agreement for Trans-Pacific Partnership that allows pharm...

Learn more